CAS No.:14842-81-0
Name: Asparkam
Details Introduction
TOXICITY DATA with REFERENCE：
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intravenous | 817mg/kg (817mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
| mouse | LD50 | oral | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
| mouse | LD50 | subcutaneous | 4226mg/kg (4226mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
| rat | LD50 | intraperitoneal | > 2gm/kg (2000mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967. | |
| rat | LD50 | intravenous | 619mg/kg (619mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
| rat | LD50 | oral | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
| rat | LD50 | subcutaneous | 6902mg/kg (6902mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. |
Consensus Reports：
Magnesium potassium aspartate (CAS NO.14842-81-0) was reported in NIIRDN Drugs in Japan (Ethical Drugs).
SAFETY PROFILE：
Moderately toxic by intravenous route. When heated to decomposition it emits toxic fumes of NOx and K2O.
Standards and Recommendations：
Analytical Methods：
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione